Bortezomib and Doxil for the Treatment of Patients With Acute Myelogenous Leukemia
Clinical trial NCT01736943 · COMPLETED
Trial details
- NCT number
- NCT01736943
- Sponsor
- Joseph Tuscano
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-19
- Primary completion
- 2019-05-20
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.